Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michèle Kind

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Diagnostic and Interventional Imaging|June 11, 2021
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapyAmandine Crombé, Lisa Gauquelin, Stéphanie Nougaret, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 24, 2021
Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European expertsBenjamin Moulin, Christina Messiou, Amandine Crombe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 5, 2002
Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcomaLaurent Gilbeau, Guy Kantor, Eberhard Stoeckle, et al.
Journal of Hematology & Oncology|October 22, 2022
Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcomaMaud Toulmonde, Sophie Cousin, Michèle Kind, et al.
Molecular Cancer|February 20, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamideMaud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, et al.
Radiology|July 26, 2006
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluationThierry de Baère, Jean Palussière, Anne Aupérin, et al.
Signal Transduction and Targeted Therapy|June 27, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumabMaud Toulmonde, Jean-Philippe Guégan, Mariella Spalato-Ceruso, et al.
Bulletin Du Cancer|November 4, 2005
[Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004]Line Claude, Sophie Rousmans, Christian Carrie, et al.
NPJ Precision Oncology|June 7, 2024
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosisAmandine Crombé, Carlo Lucchesi, Frédéric Bertolo, et al.
Journal of Hematology & Oncology|October 28, 2022
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket studyMariella Spalato-Ceruso, Fanny Bouteiller, Jean-Philippe Guegan, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Diagnostic and Interventional Imaging|June 11, 2021
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapyAmandine Crombé, Lisa Gauquelin, Stéphanie Nougaret, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 24, 2021
Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European expertsBenjamin Moulin, Christina Messiou, Amandine Crombe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 5, 2002
Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcomaLaurent Gilbeau, Guy Kantor, Eberhard Stoeckle, et al.
Journal of Hematology & Oncology|October 22, 2022
Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcomaMaud Toulmonde, Sophie Cousin, Michèle Kind, et al.
Molecular Cancer|February 20, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamideMaud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, et al.
Radiology|July 26, 2006
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluationThierry de Baère, Jean Palussière, Anne Aupérin, et al.
Signal Transduction and Targeted Therapy|June 27, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumabMaud Toulmonde, Jean-Philippe Guégan, Mariella Spalato-Ceruso, et al.
Bulletin Du Cancer|November 4, 2005
[Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004]Line Claude, Sophie Rousmans, Christian Carrie, et al.
NPJ Precision Oncology|June 7, 2024
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosisAmandine Crombé, Carlo Lucchesi, Frédéric Bertolo, et al.
Journal of Hematology & Oncology|October 28, 2022
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket studyMariella Spalato-Ceruso, Fanny Bouteiller, Jean-Philippe Guegan, et al.
Pageof 7